Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 14, 2017; 23(46): 8235-8247
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8235
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8235
Inactive, n1 = 12 | Mild activity, n2 = 12 | Moderate activity, n3 = 16 | Severe activity, n4 = 5 | |||||
FC, median (range) | 45.3 (6.7-189.42) | 474.8 (74.9-1805.0) | 769.9 (186.8-2266.1) | 1704.6 (788.4-2092.4) | ||||
P value | < 0.001 | NS | < 0.05 | |||||
CAI, median (range) | 1 (0-4) | 2.5 (1-8) | 6.5 (2-17) | 9 (8-15) | ||||
P value | < 0.05 | < 0.001 | NS | |||||
CRP, median (range) | 0.39 (0.04-2.10) | 1.9 (0.26-65.40) | 4.7 (0.08-28.19) | 16.4 (7.1-53.2) | ||||
P value | NS | NS | < 0.05 | |||||
ESR, median (range) | 4.3 (2.0-15.0) | 8.5 (2.0-40.0) | 14.0 (2.0-88.0) | 45.0 (24.0-100.0) | ||||
P value | NS | NS | < 0.05 | |||||
PCT, median (range) | 0.03 (0-0.041) | 0.031 (0.023-0.127) | 0.044 (0.021-0.538) | 0.035 (0.026-0.085) | ||||
P value | NS | NS | NS |
- Citation: Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. World J Gastroenterol 2017; 23(46): 8235-8247
- URL: https://www.wjgnet.com/1007-9327/full/v23/i46/8235.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i46.8235